The Business of Cannabis

Veteran With PTSD Helping Others In N.L. Access Medical Marijuana

May 6, 2026 | International

A veteran with post-traumatic stress disorder who runs the Newfoundland branch of Marijuana for Trauma says the drug saved his life — and Ryan Edwards is now dedicated to helping others gain access to it. A CBC News investigation has found that nearly two-thirds of...

What to Know About Medicare’s Hemp-Derived Product Program

May 6, 2026 | Feature, National

Under the program announced on April 1, “eligible hemp-derived products can be incorporated into patient care plans under clinician guidance, consistent with model requirements and applicable law,” CMS said in a press release. However, the program...

Companies With Cannabis-Based Drugs Eye Ipos, Private Funding Boost After US Reclassification

Apr 30, 2026 | National

Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets, ​providing a lifeline to the struggling cannabis industry. The U.S. Department of Justice last...

What The Trump Administration’s Move To Reclassify Marijuana Means For Investors

Apr 30, 2026 | Feature, National

CNBC’s Brandon Gomez reports on the Trump administration’s move to reclassify cannabis as a Schedule III drug. The change doesn’t legalize the drug at the federal level but it could significantly expand scientific research in the drug’s medical uses. More From...

Green Lights, Grey Zones, Red Lines: Cannabis Across Europe

Apr 23, 2026 | Europe

As of April 2026, the continent presents a patchwork of green lights, grey zones and red lines. While countries like Germany and the Czech Republic have moved to fully legalize possession and home cultivation, much of Eastern and Southeastern Europe still classifies...